HomeETON • NASDAQ
add
Eton Pharmaceuticals Inc
Previous close
$20.24
Day range
$19.63 - $20.70
Year range
$3.18 - $21.48
Market cap
543.05M USD
Avg Volume
277.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 17.28M | 116.95% |
Operating expense | 10.33M | 77.91% |
Net income | -1.57M | -93.83% |
Net profit margin | -9.10 | 10.61% |
Earnings per share | -0.06 | -100.00% |
EBITDA | 543.00K | 195.94% |
Effective tax rate | -4.94% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.42M | 4.59% |
Total assets | 84.03M | 172.88% |
Total liabilities | 59.58M | 289.42% |
Total equity | 24.45M | — |
Shares outstanding | 26.82M | — |
Price to book | 22.24 | — |
Return on assets | -1.47% | — |
Return on capital | -2.16% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -1.57M | -93.83% |
Cash from operations | 2.09M | 184.51% |
Cash from investing | — | — |
Cash from financing | 394.00K | 204.23% |
Net change in cash | 2.48M | 152.48% |
Free cash flow | -605.25K | 85.61% |
About
Founded
2017
Website
Employees
31